Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update.
about
Nanostructured lipid carriers: An emerging platform for improving oral bioavailability of lipophilic drugsIn silico, experimental, mechanistic model for extended-release felodipine disposition exhibiting complex absorption and a highly variable food interactionSelf-microemulsifying drug delivery system for improving the bioavailability of huperzine A by lymphatic uptake.A mouse model to evaluate the impact of species, sex, and lipid load on lymphatic drug transportEffects of PEGylated lipid nanoparticles on the oral absorption of one BCS II drug: a mechanistic investigationRecent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.The mesenteric lymph duct cannulated rat model: application to the assessment of intestinal lymphatic drug transportImprovement of oral availability of ginseng fruit saponins by a proliposome delivery system containing sodium deoxycholateNanoemulsions as novel oral carriers of stiripentol: insights into the protective effect and absorption enhancement.Dual-channel in-situ optical imaging system for quantifying lipid uptake and lymphatic pump function.Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.Evaluation of Pharmacokinetics, and Bioavailability of Higher Doses of Tocotrienols in Healthy Fed HumansModeling kinetics of subcellular disposition of chemicals.Engineering strategies to enhance nanoparticle-mediated oral delivery.Colonic treatments and targets: issues and opportunities.Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues.Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs.Overview of drug product development.Strategies of targeting oral drug delivery systems to the colon and their potential use for the treatment of colorectal cancer.Formulation approaches in mitigating toxicity of orally administrated drugs.Nanoemulsion-based oral delivery systems for lipophilic bioactive components: nutraceuticals and pharmaceuticals.Self-microemulsifying drug delivery system (SMEDDS)--challenges and road ahead.Recent approaches of lipid-based delivery system for lymphatic targeting via oral route.Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.Immunosuppressive drug therapy--biopharmaceutical challenges and remedies.Advances in lipid-based drug delivery: enhancing efficiency for hydrophobic drugs.Nanoformulation strategies for the enhanced oral bioavailability of antiretroviral therapeutics.Self-Assembled Lipid Nanoparticles for Oral Delivery of Heparin-Coated Iron Oxide Nanoparticles for Theranostic Purposes.Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.Controversies with self-emulsifying drug delivery system from pharmacokinetic point of view.Elucidation of intestinal absorption mechanism of carvedilol-loaded solid lipid nanoparticles using Caco-2 cell line as an in-vitro model.Lipid-based nanocarriers for the oral administration of biopharmaceutics.Preparation, in vitro evaluation and statistical optimization of carvedilol-loaded solid lipid nanoparticles for lymphatic absorption via oral administration.Demonstration of ATP-dependent, transcellular transport of lipid across the lymphatic endothelium using an in vitro model of the lacteal.Targeted lipid based drug conjugates: a novel strategy for drug delivery.Review and analysis of FDA approved drugs using lipid-based formulations.Novel lipid-free nanoformulation for improving oral bioavailability of coenzyme Q10.Improved oral bioavalability of mebudipine upon administration in PhytoSolve and Phosal-based formulation (PBF).Nonlinear absorption kinetics of self-emulsifying drug delivery systems (SEDDS) containing tocotrienols as lipophilic molecules: in vivo and in vitro studies.
P2860
Q26774831-841BC97D-0B6E-4856-9B4C-A5837692DD1FQ28543408-BF321E8A-5FB3-4FA6-90AE-598E8495E8B3Q33682598-7977CC9C-0244-4F96-99D8-30C8F7E0CB8FQ34060125-03AF8833-D6A1-4E93-B46F-B555AB61F457Q34610539-082EB100-383A-47C5-9494-3100177129EAQ34733880-C9DF5AAE-3C78-4A67-8504-EA9BBFC77E93Q35458865-48261FDA-F2E2-4F6B-8151-54C65E9012BEQ35917912-D654F2FE-7CDD-4A22-AD0D-82934AE4A56FQ35924348-8AC55982-6D20-4C73-9A84-E170EAF24E11Q36147491-FCB0D764-C9A2-45B6-97FD-CDA7E4AEA73CQ37066550-64A9FC9E-CF85-4C8E-8994-BAB2DEB015B3Q37143024-D6B5BE94-F21C-465B-AC5A-ED63CC17AA24Q37194304-F9EDAD82-EBA1-4106-B43F-2E3DCE67143AQ37328673-45E79144-53E4-416A-81CB-D71C20B6391CQ37530912-0896B0C4-850A-41EB-B2EF-CF3F4520DE69Q37587740-FA57A718-9196-4BD3-9CAE-D8909360D62AQ37702234-58009A02-367D-421F-BE59-E14CAC20834CQ37965423-499E495D-5895-4218-9C83-BBAB171CA0E9Q38017299-75005FB7-B9F3-4069-9422-07CE6C353EF1Q38073886-DD9862CC-1BCC-4A5A-8CCC-496C85FEC798Q38123857-02199E89-FDF6-40C7-B5A2-FCA07033F809Q38199539-2A5D0CB4-9348-45F2-98C9-9E3062D2742FQ38242314-ACD1DF76-B121-4F9B-85A7-71018DCB05E9Q38252593-BFAD3888-C4CC-4D1C-B6D0-A28395FB2AAEQ38340831-4657AFDF-F5A7-4262-94DC-8DAFBD6A9AAEQ38406190-D858BA55-9FC2-442B-BC3E-7C17EAF89348Q38495022-63D43C61-B058-4845-9561-F1CF6633C79FQ38700746-51B22C7B-4253-4C95-B91E-703752B2A427Q38862706-47200348-8BD8-4898-8252-7EC32731E8F2Q38926514-90E9D559-CDD7-41C2-80DC-714C6B3EFF05Q38967883-95D2C378-2606-4D35-9604-D00DBF1F523AQ38970984-74C2E5C5-EB26-4C92-B293-E0DA18D25FA4Q38990887-713CE540-9FDC-4F57-AA2C-5ACAFC5236EFQ39148643-09F9CEE9-D530-4CF6-B761-9C414FC443A5Q39311671-0E2FEF41-B004-48B1-B8B4-E8D145BEE0A3Q39332407-5E4EC5DD-C1CA-46ED-8B7B-4A93FB7C7F86Q39411779-C5722601-007F-4679-9795-AB4D25F9D881Q41060608-7073DFB4-F0E6-4A44-A5BB-540B047508FFQ41904414-31288D81-097F-44C2-9129-BF06BDDB79B7Q42084725-33119962-6555-4959-861E-6D7CF7D142EF
P2860
Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Lipid-based delivery systems a ...... ansport: a mechanistic update.
@en
Lipid-based delivery systems a ...... ansport: a mechanistic update.
@nl
type
label
Lipid-based delivery systems a ...... ansport: a mechanistic update.
@en
Lipid-based delivery systems a ...... ansport: a mechanistic update.
@nl
prefLabel
Lipid-based delivery systems a ...... ansport: a mechanistic update.
@en
Lipid-based delivery systems a ...... ansport: a mechanistic update.
@nl
P2093
P1476
Lipid-based delivery systems a ...... ansport: a mechanistic update.
@en
P2093
Christopher J H Porter
Natalie L Trevaskis
William N Charman
P304
P356
10.1016/J.ADDR.2007.09.007
P407
P577
2007-11-07T00:00:00Z